Riskpilot← Back to searchSign inGet full accessMaremma Ab
OYActiveY-tunnus 2602391-3Elinstigen 1-AMedical specialists activities · NACE 8622Est. 2014— employees
Revenue 2024
EUR 35K
+23% vs 2023
EBITDA margin
82.6%
+109% vs 2023
Equity ratio
4.4%
Financial strength
Net profit 2024
EUR 37K
+349% vs 2023
| Revenue | EUR 35K | +23% |
| EBITDA | EUR 29K | +109% |
| Net profit | EUR 37K | +349% |
| Total assets | EUR 57K | +165% |
| Equity | EUR 3K | +0% |
| Employees | — | — |
Legal name
Maremma Ab
Y-tunnus number
2602391-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
31. tammikuuta 2014
Share capital
EUR 2 550
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhetsområde är producerande av läkartjänster inom hälso- och sjukvården samt konsultation inom det medicinska området.
Address
Elinstigen 1-A
Phone
+358503673160
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 32 | 33 | 29 | 35 |
| Staff expenses | — | — | −0 | −0 |
| EBITDA | 18 | 21 | 14 | 29 |
| Depreciation & amort. | — | — | −0 | −0 |
| EBIT | 18 | 21 | 14 | 29 |
| Net financials | 10 | 12 | 0 | 0 |
| Profit before tax | 28 | 33 | 14 | 29 |
| Tax | 6 | 7 | 6 | −9 |
| Net profit | 22 | 27 | 8 | 37 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 199 | 53 | 22 | 57 |
| Equity | 159 | 27 | 3 | 3 |
| Long-term debt | — | — | 0 | 0 |
| Short-term debt | 39 | 0 | 0 | 0 |
| Total debt | 39 | 0 | 0 | 0 |
EBITDA margin
82.6%
This company
15.8%
Market median
+423% vs market
20212024
Equity ratio
4.4%
This company
38.2%
Market median
-88% vs market
20212024
Return on equity
1439.8%
This company
18.4%
Market median
+7725% vs market
20212024
Net profit margin
103.6%
This company
8.1%
Market median
+1179% vs market
20212024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20212024
Debt / equity
21.47×
This company
0.62×
Market median
-3363% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
NC Chief Executive Officer | Chief Executive Officer | 2014 |
RA Deputy Member | Deputy Member | 2018 |
LC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Maremma Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Charlotta Lindfors | Chief Executive Officer | 0 companies |
| Robert Alexander Lindfors | Deputy Member | 0 companies |
| Lars Christoffer Lindfors | Deputy Chief Executive Officer | 0 companies |
| Carl Erik Sebastian Lindfors | Board of Directors | 0 companies |